Concepedia
Statistics
Publications
5
Citations
214
H-Index
Active since
2018
Affiliations
Jinan University(Current)
Guangzhou Institutes of Biomedicine and Health
Guangzhou Regenerative Medicine and Health Guangdong Laboratory
Shanghai Institute of Materia Medica
Chinese Academy of Sciences
Xianglong Hu is an author at Jinan University specializing in drug discovery, pharmacy, and enzyme inhibition.
Publications per year
2018–2022
Pyrazolo[1,5-<i>a</i>]pyridine Inhibitor of the Respiratory Cytochrome <i>bcc</i> Complex for the Treatment of Drug-Resistant Tuberculosis
Xiaoyun Lu, Zoe C. Williams, Kiel Hards et al. · ACS Infectious Diseases · 2018 · 92 citations
Medicine, Pharmacokinetics, Pharmacology +17
Discovery of JND3229 as a New EGFR<sup>C797S</sup> Mutant Inhibitor with In Vivo Monodrug Efficacy
Xiaoyun Lu, Tao Zhang, Sujie Zhu et al. · ACS Medicinal Chemistry Letters · 2018 · 68 citations · Full text
Pharmacy, Medicinal Chemistry, Oncology +11
Identification of Pyrazolo[1,5-<i>a</i>]pyridine-3-carboxamide Diaryl Derivatives as Drug Resistant Antituberculosis Agents
Xianglong Hu, Baojie Wan, Yang Liu et al. · ACS Medicinal Chemistry Letters · 2019 · 21 citations
Pharmacy, Pharmacokinetics, Pharmacology +17
2-Oxo-3,4-dihydropyrimido[4,5-d] pyrimidines as new reversible inhibitors of EGFR C797S (Cys797 to Ser797) mutant
Xianglong Hu, Qiuju Xun, Tao Zhang et al. · Chinese Chemical Letters · 2019 · 19 citations
Discovery of 1-hydroxy-2-methylquinolin-4(1H)-one derivatives as new cytochrome bd oxidase inhibitors for tuberculosis therapy
Yang Zhou, Min Shao, Weiwei Wang et al. · European Journal of Medicinal Chemistry · 2022 · 14 citations
Pharmacy, Medicinal Chemistry, Pharmacology +11
1–5 of 5